Welcome to Bruker's activities during ASMS 2022 taking place from June 5 - 9, 2022, in Minneapolis.
Our events will start on Sunday, June 5, at 8:30 am with our eXceed Symposia in the Hyatt Regency. Please see details on the agenda below.
From Monday to Wednesday you can hear about our latest technologies in our Breakfast Workshops focusing on Proteomics, BioPharma and Imaging. The Breakfast Workshosp will take place at 7:00 am in the Minneapolis Convention Center, Room 200 DE on the second level.
And be sure to also visit our Hospitality Suite in the Hilton Minneapolis and stop by our Bruker Booth #407 in Halls B and C to see our instruments displayed.
Sunday, June 5, 2022, 8:30 am – 1 pm CDT, Hyatt Regency, Minneapolis
Plenary Session: Enhancing Workflow Capabilities for Translational Mass Spectrometry
08:30-08:45 Welcome & Introduction
Rohan A. Thakur, Ph.D., President, Life Sciences Mass Spectrometry Division, Bruker, Fällanden, Switzerland
08:45-09:05 Proteomics at Scale – Actionable Insights to Drug Discovery & Translational Research
Ashok Dongre, Ph.D., Director & Head Proteomics, Bristol-Myers Squibb, USA
09:05-09:25 Single cell based diagnostics: translation imaging mass spectrometry
Prof. Ron Heeren, Ph.D., Director and Division Head Imaging Mass Spectrometry, Maastricht MultiModal Molecular Imaging Institute, M4i, Maastricht University, Maastricht, Netherlands
09:25-09:45 Benefits of Collisional Cross Section Assisted Precursor Selection for Cross-linking Mass Spectrometry and Glycoproteomics
Prof. Albert J. R. Heck, Ph.D., Distinguished Faculty Professor Utrecht University, Scientific Director Netherlands Proteomics Centre, Utrecht, Netherlands
09:45-10:15 Break
10:15 Start of Breakout Sessions
Breakout #1 Proteomics – Enhancing Workflow Capabilities of Single Cell and Translational Proteomics
10:15-10:30 Analysis of a single cell to the plasma proteome
Chris Adams, Ph.D., Business Development Director, Global Bioinformatics, Life Science Mass Spectrometry, Bruker Daltonics, Billerica, MA, USA
10:30-10:55 Nanoparticle-based enrichment coupled with Bruker timsTOF Pro 2 platform facilitates unbiased and reproducible plasma proteomics for biomarker discovery at scale
Bruce Wilcox, Ph.D., VP Proteomics, PrognomiQ, San Mateo, CA, USA
10:55-11:20 High sensitivity and deep coverage immunopeptidomics on the timsTOF Pro 2 and SCP
Prof. Stefan Tenzer, Ph.D., Head of Mass Spectrometry Core Facility, University Medical Center, Mainz, Germany
11:20-11:45 Unraveling multi-level tissue heterogeneity at single-cell and low input using the timsTOF SCP
Claudia Ctortecka, Ph.D., Postdoctoral Fellow, Carr Laboratory, Broad Institute of MIT and Harvard, Cambridge, MA, USA
11:45-12:00 Break
12:00-12:25 Boosting proteome depth of coverage by ion mobility fractionation in combination with PASEF approaches on a TIMS-QTOF instrument
Stanley Stevens, Ph.D., Associate Professor, Department of Cell Biology, Microbiology and Molecular Biology, University of South Florida, Tampa, FL, USA
12:25-12:50 A Fit-for-Purpose Approach to Detect Amino Acid Substitutions in Shotgun Proteomics
Matthew Champion, Ph.D., Associate Professor, Department of Chemistry & Biochemistry, University of Notre Dame, Notre Dame, IN, USA
Breakout #2 Pharma/BioPharma - Enhancing Workflow Capabilities in Pharma and Biopharma
10:15-10:30 Introduction
Mike Greig, Ph.D., Director, Pharma/BioPharma Americas, Bruker Daltonics, Billerica, MA, USA
10:30-11:05 Large-Scale Mass Spectrometry Profiling for Accelerated Biomarker Discovery
Jeramie Watrous, Ph.D., Co-Founder and Head of Analytical R&D, Sapient, San Diego, CA, USA
11:05-11:40 Mapping progressively larger RNAs without front-end separations
Dan Fabris, Ph.D., Harold S. Schwenk Sr. Distinguished Chair in Chemistry, Department of Chemistry, University of Connecticut, Mansfield, CT, USA
11:40-12:00 Break
12:00-12:30 High-Throughput Host Cell Protein Analysis in Industrial Biotechnology
Christian Jörgensen, Ph.D., Novozymes A/S, Bagsvaerd, Denmark
12:30-1:00 Rapid Characterization of Bispecific Antibodies using Phase Appropriate LC-MS Strategy
Na Parra, Ph.D., Co-Founder & Executive Vice President of Marketing at LiVeritas Biosciences, South San Francisco, CA, USA
Breakout #3 Imaging - Enhancing Workflow Capabilities through Spatial Contextualization
10:15-10:25 Introduction
Mike Easterling, Ph.D., Business Unit Manager, Imaging/MRMS, Bruker Daltonics, Billerica, MA, USA
10:25-10:45 Behind the scenes with the PC-mass tag developers
Mark Lim, Ph.D., Executive Vice President and Chief Scientific Officer, AmberGen Inc., Watertown, MA, USA
10:45-11:15 First Impressions of the MALDI HiPLEX IHC Workflow
Reid Groseclose, Ph.D., Director/GSK Fellow, GlaxoSmithKline, Philadelphia, PA, USA
11:15-11:45 Spatial contextualization in Pharma Spaces
Joey Latham, Ph.D., Senior Director, Bioanalytical Science at PTC Therapeutics, Mountain View, CA, USA
11:45-12:00 Break
12:00-12:30 Preclinical Applications of Targeted Drug and Protein Imaging
John Bowling, Ph.D., Staff Scientist, Analytical Technologies Center, St. Jude Children's Research Hospital, Memphis, TN, USA
12:30-1:00 Multiplexing Spatial Proteomics of Matrix Biology in Human Health and Disease
Peggi Angel, Ph.D., Associate Professor, Department of Cell & Molecular Pharmacology & Experimental Therapeutics, Medical University of South Carolina, Charleston, SC, USA
Ashok Dongre, Ph.D., Director & Head Proteomics, Bristol-Myers Squibb, USA
Prof. Ron Heeren, Ph.D., Director and Division Head Imaging Mass Spectrometry, Maastricht MultiModal Molecular Imaging Institute, M4i, Maastricht University, Maastricht, Netherlands
Prof. Albert J. R. Heck, Ph.D., Distinguished Faculty Professor Utrecht University, Scientific Director Netherlands Proteomics Centre, Utrecht, Netherlands
Bruce Wilcox, Ph.D., VP Proteomics, PrognomiQ, San Mateo, CA, USA
Prof. Stefan Tenzer, Ph.D., Head of Mass Spectrometry Core Facility, University Medical Center, Mainz, Germany
Claudia Ctortecka, Ph.D., Postdoctoral Fellow, Carr Laboratory, Broad Institute of MIT and Harvard, Cambridge, MA, USA
Stanley Stevens, Ph.D., Associate Professor, Department of Cell Biology, Microbiology and Molecular Biology, University of South Florida, Tampa, FL, USA
Matthew Champion, Ph.D., Associate Professor, Department of Chemistry & Biochemistry, University of Notre Dame, Notre Dame, IN, USA
Jeramie Watrous, Ph.D., Co-Founder and Head of Analytical R&D, Sapient, San Diego, CA, USA
Dan Fabris, Ph.D., Harold S. Schwenk Sr. Distinguished Chair in Chemistry, Department of Chemistry, University of Connecticut, Mansfield, CT, USA
Na Parra, Ph.D., Co-Founder & Executive Vice President of Marketing at LiVeritas Biosciences, South San Francisco, CA, USA
Mark Lim, Ph.D., Executive Vice President and Chief Scientific Officer, AmberGen Inc., Watertown, MA, USA
Reid Groseclose, Ph.D., Director/GSK Fellow, GlaxoSmithKline, Philadelphia, PA, USA
Joey Latham, Ph.D., Senior Director, Bioanalytical Science at PTC Therapeutics, Mountain View, CA, USA
John Bowling, Ph.D., Staff Scientist, Analytical Technologies Center, St. Jude Children's Research Hospital, Memphis, TN, USA
Peggi Angel, Ph.D., Assistant Professor, Department of Cell & Molecular Pharmacology & Experimental Therapeutics, Medical University of South Carolina, Charleston, SC, USA
7:00-7:15 Welcome and introduction
Chris Adams, Ph.D., Business Development Director, Global Bioinformatics, Life Science Mass Spectrometry, Bruker Daltonics, Billerica, MA, USA
7:15-7:30 Medium Depth High Throughput Proteomics Profiling using dia-PASEF for agricultural and biological fluid applications in a core facility
Brett Phinney, Ph.D., Director Proteomics Core, Genome Center, University of California, Davis, CA, USA - Abstract
7:30-7:45 4D Proteomic Profiling of 200 Individuals: A High Throughput Workflow from Sample Preparation, dia-PASEF and PASER-MS to Profiling
Qin Fu, Ph.D., Director, High Throughput Center, Advanced Clinical Biosystems Research Institute, Smidt Heart Institute, Cedars Sinai Medical Center, Los Angeles, CA, USA - Abstract and Bio
7:45-8:00 Deep and Unbiased Plasma Proteomics Analysis of Alzheimer’s and Mild Cognitive Impairment Subjects with a Novel Multi-nanoparticle Approach
Mahdi Zamanighomi, Ph.D., Principal Machine Learning Researcher, Seer, Inc., Redwood City, California, USA - Bio
8:00-8:15 Making a Smart-Instrument: APIo and Bidirectional Communication
Patrick Ty Garrett, Graduate student, Dr. John Yates Lab, The Scripps Research Institute, La Jolla, CA, USA - Abstract and Bio
7:00-7:10 Welcome and introduction
Mike Greig, Ph.D., Director, Pharma/BioPharma Americas, Bruker Daltonics, Billerica, MA, USA
7:10-7:35 One-Pot Exosome Proteomics Enabled by a Photocleavable Surfactant
Kevin Buck, Graduate Student, Department of Chemistry, University of Wisconsin-Madison, Madison, WI, USA
7:35-8:00 High throughput chemo-proteomic approaches for mapping the degradable proteome
Katherine Donovan, Ph.D., Senior Scientist, Proteomics Group Lead, Eric Fischer Lab, Dana-Farber Cancer Institute, Boston, MA, USA - Abstract
8:00-8:15 Streamlined & automated sample processing for in-depth proteomic analyses
Garwin Pichler, Ph.D., CEO, PreOmics GmbH, Planegg/Martinsried, Germany - Abstract
7:00-7:05 Welcome and introduction
Kate Stumpo, Business Development Manager, SpatialOMx, Bruker Daltonics, Billerica, MA, USA
7:05-7:25 Simultaneous Quantitation of Multiple Analytes with Mass Spectrometry Imaging
Sylwia Stopka, Ph.D., Postdoctoral Fellow, Brigham & Women's Hospital, Harvard Medical School, Boston, MA, USA - Abstract and Bio
7:25-7:45 Visualizing neurodegenerative diseases with multiple layers of biochemical detail
Prof. Per Andren, Ph.D., Medical Mass Spectrometry, Department of Pharmaceutical Biosciences, Uppsala University, Uppsala, Sweden - Abstract and Bio
7:45-8:05 Unraveling the spatial lipidome using gas-phase ion/ion reactions
Boone Prentice, Assistant Professor, Department of Chemistry, University of Florida, Gainesville, FL, USA
8:05 Live Q&A
For Research Use Only. Not for use in clinical diagnostic procedures.